Retinal Dystrophy Treatment Market: Why Does Only One Genetic...

agregó una foto Health

2026-07-27 07:54:22 -

Retinal Dystrophy Treatment Market: Why Does Only One Genetic Mutation Out of Hundreds Have an Approved Gene Therapy?

The retinal dystrophy treatment market — therapies for a genetically diverse group of inherited eye disorders causing progressive degeneration of retinal photoreceptors and eventual vision loss or blindness — has been transformed by the landmark 2017 approval of the first ocular gene therapy, even as the vast majority of the more than 270 identified disease-causing genes remain...

0 Commentarios 0 Acciones 9 Views 0 Vista previa